Skip to main content

Advertisement

Log in

Long-term survival after multidisciplinary therapy for brain metastases from asymptomatic esophageal adenocarcinoma

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Asymptomatic T1 (invaded submucosa) esophageal carcinoma rarely metastasizes to the brain. A 53-year-old Japanese man complaining of right hemiparesis and convulsion was admitted to our hospital. Brain imaging demonstrated a ring-like, enhanced brain tumor in the left parietal lobe. The pathological findings of the resected tumor were consistent with a metastatic adenocarcinoma from the gastrointestinal tract. Additional examinations revealed an elevated-type tumor in the lower third of the thoracic esophagus. The patient underwent thoracoscopic esophagectomy with lymph node dissection followed by reconstruction with gastric tube substitution. The immunohistochemical findings of the resected specimen were similar to those of the metastatic brain tumor. Although the patient received adjuvant chemotherapy (5-fluorouracil, docetaxel plus cisplatin), a solitary small brain metastasis was detected 4 months after esophagectomy. Excision of the sequential metastases with whole-brain radiation therapy and gamma-knife therapy were performed. The patient survived for 50 months after beginning the initial treatment. This report describes a rare case of brain metastases from T1 esophageal adenocarcinoma in a patient without gastrointestinal symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hori M, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884–91.

    Article  PubMed  Google Scholar 

  2. Rubenstein JH, Shaheen NJ. Epidemiology, diagnosis, and management of esophageal adenocarcinoma. Gastroenterology. 2015;149:302–17.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Yoshida S. Brain metastasis in patients with esophageal carcinoma. Surg Neurol. 2007;67:288–90.

    Article  PubMed  Google Scholar 

  4. Gabrielsen TO, Eldevik OP, Orringer MB, et al. Esophageal carcinoma metastatic to the brain: clinical value and cost-effectiveness of routine enhanced head CT before esophagectomy. AJNR Am J Neuroradiol. 1995;16:1915–21.

    CAS  PubMed  Google Scholar 

  5. Ogawa K, Toita T, Sueyama H, et al. Brain metastases from esophageal carcinoma: natural history, prognostic factors, and outcome. Cancer. 2002;94:759–64.

    Article  PubMed  Google Scholar 

  6. Quint LE, Hepburn LM, Francis IR, et al. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 1995;76:1120–5.

    Article  CAS  PubMed  Google Scholar 

  7. Burkitt P, Carter LM, Smith AB, et al. Outcomes of percutaneous endoscopic gastrostomy and radiologically inserted gastrostomy in patients with head and neck cancer: a systematic review. Br J Oral Maxillofac Surg. 2011;49:516–20.

    Article  CAS  PubMed  Google Scholar 

  8. Song Z, Lin B, Shao L, Zhang Y. Brain metastases from esophageal cancer: clinical review of 26 cases. World Neurosurg. 2014;81:131–5.

    Article  PubMed  Google Scholar 

  9. Weinberg JS, Suki D, Hanbali F, et al. Metastasis of esophageal carcinoma to the brain. Cancer. 2003;98:1925–33.

    Article  PubMed  Google Scholar 

  10. Chaichana KL, Gadkaree S, Rao K, et al. Patients undergoing surgery of intracranial metastases have different outcomes based on their primary pathology. Neurol Res. 2013;35:1059–69.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg. 1940;112:138–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bekki Y, Kimura Y, Morita M, et al. Esophageal cancer associated with bilateral hilar lymphadenopathy caused by sarcoid-like reactions: a report of two cases. Esophagus. 2015;12:322–6.

    Article  Google Scholar 

  13. Feng W, Zhang P, Zheng X, et al. Incidence and treatment of brain metastasis in patients with esophageal carcinoma. World J Gastroenterol. 2015;21:5805–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Abu Hejleh T, Deyoung BR, Engelman E, et al. Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patients. World J Gastrointest Oncol. 2012;4:103–8.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Preusser M, Berghoff AS, Ilhan-Mutlu A, et al. Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapies. Anticancer Res. 2013;33:1065–71.

    PubMed  Google Scholar 

  16. Safran H, Dipetrillo T, Akerman P, et al. Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma. Int J Radiat Oncol Biol Phys. 2007;67:405–9.

    Article  CAS  PubMed  Google Scholar 

  17. Kim JC, Lee JL, Yoon YS, et al. Utility of indocyanine-green fluorescent imaging during robot-assisted sphincter-saving surgery on rectal cancer patients. Int J Med Robot. 2016;12:710–7.

    Article  PubMed  Google Scholar 

  18. Cinar P, Calkins SM, Venook AP, et al. A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma. Anticancer Res. 2014;34:7357–60.

    PubMed  Google Scholar 

  19. Joo HY, Chae MH, Lim JH, et al. A case of gastric cancer manifesting as a solitary brain metastasis in the cerebellopontine angle that mimicked acoustic neuroma. Chonnam Med J. 2013;49:133–5.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kothari N, Mellon E, Hoffe SE, et al. Outcomes in patients with brain metastasis from esophageal carcinoma. J Gastrointest Oncol. 2016;7:562–9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takeshi Matsutani.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human rights

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from the patient and patient’s family to be included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsutani, T., Hagiwara, N., Nomura, T. et al. Long-term survival after multidisciplinary therapy for brain metastases from asymptomatic esophageal adenocarcinoma. Clin J Gastroenterol 11, 113–117 (2018). https://doi.org/10.1007/s12328-017-0803-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-017-0803-7

Keywords

Navigation